Showing 7161-7170 of 18629 results for "".
B-Cell Therapy: When Is It Right for Our MS Patients?
https://reachmd.com/programs/frontlines-multiple-sclerosis/b-cell-therapy-when-is-it-right-for-our-ms-patients/13722/B-cell depletion therapies have shown to prevent relapses in multiple sclerosis, but their exact role is unclear. Here’s what we know so far.The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
https://reachmd.com/programs/project-oncology/the-necessity-of-a-multidisciplinary-approach-through-the-mcrpc-treatment-journey/17802/A multidisciplinary care approach is pivotal in the disease continuum of mCRPC. Here’s why.Adenoma Detection Rate: A Prediction of Colorectal Cancer
https://reachmd.com/programs/gi-insights/adenoma-detection-rate-a-prediction-of-colorectal-cancer/14232/What do we need to know about adenoma detection rate—and can it help predict our patients’ risk of developing colorectal cancer?Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
https://reachmd.com/programs/project-oncology/optimizing-multiple-myeloma-care-advances-for-newly-diagnosed-patients/26582/Tune in to learn about the latest treatments for patients with newly diagnosed multiple myeloma.COVID-19 Reflections: How to Address Vaccine Messaging and Public Health Challenges
https://reachmd.com/programs/clinicians-roundtable/covid-19-reflections-how-to-address-vaccine-messaging-and-public-health-challenges/29091/Here to share his perspective on how we can address the public health challenges stemming from the COVID-19 pandemic is Dr. Aslam Khan.Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
https://reachmd.com/programs/project-oncology/overall-survival-with-neoadjuvant-therapy-in-hnscc/32999/Despite recent therapeutic advances, long-term survival in head and neck squamous cell carcinoma (HNSCC) remains suboptimal. A new study compared overall survival outcomes associated with neoadjuvant systemic therapy in patients with resectable disease. Hear from Dr. Vanessa Helou as she shares theOptimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
https://reachmd.com/programs/frontlines-schizophrenia/optimizing-schizophrenia-care-strategies-for-managing-side-effects-and-treatment-resistance/30035/Learn about strategies for managing common therapeutic challenges in schizophrenia.Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
https://reachmd.com/programs/heart-matters/addressing-unmet-needs-in-attr-cm-care-key-considerations-for-optimal-management/33060/Explore challenges in diagnosing and treating transthyretin cardiac amyloidosis and how we can address them.Optimizing mCRPC Care: Treatment Selection and Sequencing Strategies
https://reachmd.com/programs/project-oncology/optimizing-mcrpc-care-treatment-selection-and-sequencing-strategies/28643/Here’s how we can select and sequence appropriate treatment options for our patients with metastatic castration-resistant prostate cancer.Antiphospholipid Syndrome: Unraveling a Complex Autoimmune Disorder
https://reachmd.com/programs/living-rheum/antiphospholipid-syndrome-unraveling-a-complex-autoimmune-disorder/24326/Antiphospholipid Syndrome is a challenging and complex autoimmune condition characterized by abnormal blood clotting. Here's the latest on current treatments and research.